A Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) Subjects
Clinical trial NCT02275481 · TERMINATED
Trial details
- NCT number
- NCT02275481
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2016-09-14
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.